Articles tagged with Adipocytes
Researchers at PolyU have identified a key driver of tumour growth in liver cancer and developed a monoclonal antibody that neutralises this protein. The antibody inhibits the growth and proliferation of FABP4-driven cancer stem cells, enhancing immune cell activity.
Research shows that beige fat surrounding blood vessels helps regulate blood pressure, promoting healthy vascular function even during obesity. Activating thermogenic fat tissue may reduce the risk of cardiovascular disease. Beige perivascular adipose tissue supports healthy blood vessels and blood pressure control.
Research reveals that fat located near the colon contains an unusually high number of inflammatory fat cells and immune cells, suggesting a unique function in communicating with the immune system in the gut region. This tissue may be an adaptation to the gut microbiome and could contribute to amplifying or sustaining inflammation.
A study found that reducing amino acids methionine and cysteine in lab mice' diets led to significant weight loss through increased thermogenesis, similar to cold-induced methods. The research team believes this could be a promising approach for obesity treatments and developing functional food products.
Researchers at Salk Institute discover a new microprotein, SLC35A4-MP, that regulates mitochondrial structure and function in brown fat tissue. The study reveals the microprotein's role in maintaining healthy cellular metabolism and regulating body temperature.
Breast cancer cells build molecular tunnels into nearby fat cells to release energy, blocking gap junctions stops tumor growth. The discovery provides a golden opportunity for developing effective strategies to treat the most aggressive forms of breast cancer.
Researchers at the Salk Institute have identified dozens of microproteins that play a crucial role in regulating fat cell proliferation and lipid accumulation. This breakthrough discovery offers new potential drug targets for treating obesity and metabolic disorders, building on recent advances in CRISPR gene editing technologies.
A new study found that excessive oleic acid in olive oil drives fat cell growth, increasing the risk of obesity. High levels of oleic acid stimulate the proliferation of precursor cells that form new fat cells, leading to a larger capacity for storing excess nutrients.
A Virginia Tech professor has received a proof-of-concept grant to further develop a chemical compound that could help promote weight loss by increasing mitochondrial activity. The compound, named BAM15, shows promise in preclinical studies without affecting food intake or muscle mass.
A team of researchers at Kyoto University has found that cells can hear and respond to sound waves, leading to potential applications in medicine and healthcare. The study used acoustic pressure to induce cellular responses, revealing the suppression of fat cell formation and activation of mechanosensitive genes.
Researchers developed a dual-action nanotherapy that converts white fat into beige fat and reduces obesity-related inflammation, significantly improving metabolic health without detectable toxicity.
A team of Chinese researchers identified a novel intercellular signaling mechanism between adipocytes and hepatocytes in endoplasmic reticulum stress response. The study reveals that ceramide, a fat molecule, plays a key role in activating the unfolded protein response pathway in hepatocytes.
Researchers found that CD44-deficient mice stayed lean despite a high-fat diet, while control mice developed obesity. The study suggests CD44 inhibitors could serve as a complementary treatment for obesity and related metabolic disorders.
A new study identified unique subpopulations of fat cells with complex predicted functions, and even found differences between human fat tissues in intercellular communication. The discovery provides a basis for further research to advance personalized medicine in obesity.
Researchers at UCSF used CRISPR gene editing technology to transform ordinary white fat cells into 'beige' fat cells that voraciously consume calories to make heat. Implanted near tumors, these cells outcompeted cancer cells for nutrients, beating back five types of cancer in lab experiments.
Researchers at Osaka University identified ARMC5 as a degradation factor for SREBP1, essential for maintaining balance in adipose tissue. This discovery may lead to the development of novel drugs regulating saturated and unsaturated fatty acid levels.
Researchers identify caveolae's role in protecting adipocytes from rupture and inflammation; this discovery opens new avenues for treating metabolic diseases like obesity. The study highlights the importance of the caveolin-1 protein in maintaining cellular integrity.
Researchers discovered a new component of the peripheral nervous system that acts by increasing energy metabolism in the body. This finding paves the way for simpler and cheaper drugs to control obesity and weight gain.
Researchers at Anglia Ruskin University are investigating the complex relationship between fat tissue and colorectal cancer. The study aims to enhance knowledge of the tumour microenvironment, uncover new molecules crucial for cancer growth, and develop more effective treatments.
Adipo Therapeutics' lead product ADPO-002NP shows promising results in increasing energy expenditure and improving insulin resistance by browning white adipose tissue. The company is now raising $8 million to move the treatment to first-in-human Phase I clinical trials.
Scientists identify PICALM as a key player in regulating glucose homeostasis and insulin signaling in adipocytes. Reduced expression of PICALM improves insulin sensitivity and glucose transport, holding promise for new therapeutic approaches for type 2 diabetes and obesity.
Research from the University of Eastern Finland found that obesity-induced inflammation increases the secretion of extracellular vesicles from human adipocytes, which may contribute to the detrimental health effects of obesity. Visceral adipose tissue secretes more extracellular vesicles than subcutaneous adipose tissue.
Researchers have discovered a new type of beige fat cells that consume energy and produce heat through a futile-cycle mechanism, known as the 'Sisyphus mechanism'. These cells are found in adults and help break down excess fat, leading to improved metabolic health and reduced risk of obesity.
Dr. Elks' research focuses on the communication loop between fat cells and immune cells, which promotes inflammation and insulin resistance when disrupted. The grant aims to uncover patterns in cell communication that can be used to treat obesity and other metabolic diseases.
Researchers at UCSF have discovered a way to turn ordinary white fat cells into beige fat cells that burn calories, opening the door to developing new weight-loss drugs. The approach uses a protein called KLF-15 and may avoid side effects associated with current treatments.
A Swedish study found that individuals with large fat cells tend to lose weight over time, while those with small fat cells gain weight. The study suggests that measuring the size of fat cells could be important for weight management later in life.
Researchers have identified a population of mesothelial-like cells in omental adipose tissue that limit fat cell formation, offering new insights into the mechanisms underlying obesity. These cells secrete Insulin-like Growth Factor Binding Protein 2, which inhibits adipogenesis and regulates metabolic behavior.
Researchers found decreased BMAd density and altered distribution profile in MGUS patients who developed MM, indicating early changes in bone marrow adipose tissue. These findings suggest the potential for timely interventions and personalized treatment strategies.
A groundbreaking study identifies FAM3C as a key regulator of breast cancer progression within the tumor microenvironment. The overexpression of FAM3C promotes breast cancer cell survival and metastasis, while its depletion inhibits tumor growth in genetically engineered mouse models.
Brown fat cells convert energy into heat, protecting against cardiovascular diseases. Researchers discovered a new protein, EPAC1, that increases brown fat mass and activity, offering a potential target for weight loss therapies.
Researchers found that p53-mutated breast cancer cells reprogram fat cells to create an inflammatory microenvironment, impairing the immune response against the tumor. This interaction drives cancer growth and is a key driver of tumor-promoting reprogramming of fat cells.
Researchers discovered five types of macrophages in fat tissue, with one subtype promoting inflammation and another quelling it. The findings challenge the long-held assumption that pro-inflammatory macrophages are solely responsible for obesity-related inflammation.
A new model for producing human brown fat cells in vitro has been developed, providing a potential solution for treating obesity and type 2 diabetes. The researchers identified key cellular signaling cues that lead to brown adipocyte formation and successfully reproduced this process in human pluripotent stem cells.
A groundbreaking study by UNIST researchers reveals that high levels of endotrophin in fat cells disrupt autophagy, leading to inflammation and insulin resistance. Inhibiting ATG7 protein function or neutralizing endotrophin shows promise as a potential treatment for obesity-related metabolic diseases.
Researchers found that healthy breast adipocytes secrete IGFBP2, which acts as a barrier against invasive breast cancer progression. Lower IGFBP2 levels with age may contribute to increased breast cancer risk.
Scientists at the University of Copenhagen discovered a new type of fat cell called SWAT cells that provide structural integrity to adipose tissue. These flexible cells can differentiate into various types, including fat cells and progenitor cells, suggesting a crucial role in adapting to metabolic conditions.
Researchers have identified a new mechanism of communication between fat cells, opening up avenues for novel obesity treatments. The discovery centers on tunnelling nanotubes, which allow distant cells to communicate directly and transfer cargos.
New research suggests a way to ward off age-related weight gain by stimulating beige fat cells. Beige fat has thermogenic properties that can reduce blood sugar and fatty acids causing heart disease. The study identifies a specific signaling pathway responsible for suppressing beige fat formation in older mice.
Scientists have found that cells break down and reassemble fatty acids to create more beneficial variants, such as oleic acid. This process, called triglyceride cycling, refines poorly usable fatty acids into higher-quality forms.
A team of researchers from Ohio University discovered that CIDEC protein improves vascular and metabolic dysfunction, reducing insulin resistance and lipid levels in high-fat diet-induced mice. The study contributes to understanding the role of the vascular endothelium in regulating systemic metabolism.
The study found that phenolic extracts from roselle inhibited fat cell formation by 95%, while hydroxycitric acid had no effect. Researchers hope the plant's antioxidants can be used in health food products to manage obesity without side effects.
Researchers found that Sirtuin 7 regulates brown adipose tissue functions, leading to suppressed energy expenditure and thermogenesis. The study reveals a molecular pathway involving protein deacylation and mRNA binding, which will have implications for treating hypermetabolic conditions like cancer and obesity.
A study suggests that visceral fat cells, rather than subcutaneous fat cells, are more susceptible to infection by the COVID-19 virus. This increased susceptibility leads to a higher viral load and production of pro-inflammatory cytokines, which can exacerbate severe disease.
Researchers explore the interactions between adipose tissues and surrounding blood vessels in connection with lipid metabolism and associated diseases. Targeting angiogenesis may provide a gateway for treating obesity, while its inhibition or promotion depends on the specific disease context.
Researchers discovered that stopping GH activity in fat cells improves health and increases lifespan in mice. The study found approximately 23% lifespan extension due to GHR disruption, with improved insulin sensitivity and reduced frailty scores.
A team of scientists at Scripps Research and Calibr discovered a naturally occurring metabolite called myristoylglycine that can convert white fat cells into brown fat cells, potentially treating obesity and related diseases. The breakthrough uses a novel drug discovery method to identify endogenous metabolites with therapeutic potential.
A study found that high-fat diets fuel the creation of inflammatory immune cells in mouse bone marrow. These cells can later invade fat tissue, leading to insulin resistance and other complications associated with obesity. The bone marrow's sensitivity to environmental changes plays a crucial role in this process.
Researchers at Weill Cornell Medicine found that disrupting circadian clocks leads to increased fat cell growth and insulin production. Stress and other factors can throw the body's 'clocks' out of rhythm, contributing to weight gain.
A new molecule, inosine, has been identified as a key booster of fat burning through activation of brown fat cells. Studies have shown that inosine can increase energy consumption and protect against diabetes in mice fed high-energy diets.
A new study found that crown-like structures surrounding breast tumors in overweight and obese patients can hinder their response to therapy. Researchers identified a potential molecular biomarker, CD32B, which is associated with poorer treatment outcomes.
An artificial intelligence model trained on histological images of surgical specimens accurately classified patients with and without Crohn disease recurrence. The model revealed previously unrecognized differences in adipose cells and mast cell infiltration, enabling stratification by prognosis for postoperative Crohn disease patients.
A novel therapy using sustained release of nitric oxide has been shown to ameliorate obesity and Type 2 diabetes in mice fed a high-fat diet. The therapy was found to decrease body weight, improve glucose tolerance, and stimulate the browning of adipose tissue.
A study by Osaka University investigated the relationship between autophagy and metabolism during fasting. Autophagy was found to play a key role in promoting fat loss during fasting, particularly through the upregulation of adipogenic genes. The findings may have important implications for understanding metabolism during aging.
Researchers at the University of Virginia Health System have identified a potential way to treat obesity and type 2 diabetes in women by targeting a specific gene called KLF14. Increasing KLF14 abundance in fat cells may help alleviate metabolic abnormalities, including slower metabolic rates and less efficient triglyceride management.
A new study by EPFL researchers finds that stress during early adolescence leads to increased body fat and reduced sociability in males, but not females. The researchers identified a biological link between stress-induced fat gain and impaired brain function, specifically the NAD+/Sirtuin-1 pathway.
A new University of Copenhagen study reveals that well-functioning fat tissue is crucial for overall health and may help prevent diseases such as type 2 diabetes, cancer, and obesity. High levels of lifelong exercise have been shown to improve mitochondrial function in fat cells, reducing oxidative stress and damage.
Researchers from Tel Aviv University have engineered 3D human spinal cord tissues and implanted them in lab models with long-term chronic paralysis, resulting in an 80% success rate in restoring walking abilities. The team aims to conduct clinical trials in human patients within a few years to make the treatment commercially available.
Research reveals that obesity leads to a decline in adipose tissue's ability to respond to changes, causing insulin resistance and inflammation. This loss of function can be addressed through modulating fat tissue phenotypes for therapeutic purposes.
Research found that over 55,000 chemicals in everyday plastic products can reprogram precursor cells to become fat cells, leading to increased fat accumulation. The study suggests that previously unknown plastic chemicals may be contributing to overweight and obesity.
Scientists at Nanyang Technological University have developed a novel therapeutic approach to tackle obesity, reducing body fat and improving blood markers through a hydrogel injection and near infrared light treatment. The treatment shows significant promise in lab trials, with mice experiencing reduced body mass and improved metabolism.